NO893135D0 - Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater. - Google Patents

Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.

Info

Publication number
NO893135D0
NO893135D0 NO893135A NO893135A NO893135D0 NO 893135 D0 NO893135 D0 NO 893135D0 NO 893135 A NO893135 A NO 893135A NO 893135 A NO893135 A NO 893135A NO 893135 D0 NO893135 D0 NO 893135D0
Authority
NO
Norway
Prior art keywords
butadienyl
tri
tetraaminoalkander
derivatives
procedure
Prior art date
Application number
NO893135A
Other languages
English (en)
Other versions
NO893135L (no
NO172043C (no
NO172043B (no
Inventor
Philippe Bey
David Martin Stemerick
Michael Louis Edwards
Alan Joseph Bitonti
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO893135D0 publication Critical patent/NO893135D0/no
Publication of NO893135L publication Critical patent/NO893135L/no
Publication of NO172043B publication Critical patent/NO172043B/no
Publication of NO172043C publication Critical patent/NO172043C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/21—Monoamines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A01N33/04—Nitrogen directly attached to aliphatic or cycloaliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO893135A 1988-08-04 1989-08-03 Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater NO172043C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/228,620 US4935449A (en) 1988-08-04 1988-08-04 N-2,3-butadienyl tri- and tetraaminoalkane derivatives

Publications (4)

Publication Number Publication Date
NO893135D0 true NO893135D0 (no) 1989-08-03
NO893135L NO893135L (no) 1990-02-05
NO172043B NO172043B (no) 1993-02-22
NO172043C NO172043C (no) 1993-06-02

Family

ID=22857945

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893135A NO172043C (no) 1988-08-04 1989-08-03 Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater

Country Status (19)

Country Link
US (1) US4935449A (no)
EP (1) EP0353752B1 (no)
JP (1) JP2722255B2 (no)
KR (1) KR0144155B1 (no)
CN (1) CN1039800A (no)
AT (1) ATE99669T1 (no)
AU (1) AU617502B2 (no)
CA (1) CA1321603C (no)
DE (1) DE68912020T2 (no)
DK (1) DK381189A (no)
ES (1) ES2061826T3 (no)
FI (1) FI893681A (no)
HU (1) HU207833B (no)
IL (1) IL91184A0 (no)
NO (1) NO172043C (no)
NZ (1) NZ230155A (no)
PH (1) PH27214A (no)
PT (1) PT91365A (no)
ZA (1) ZA895840B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111794D0 (en) * 1991-05-31 1991-07-24 Robins David J Antifungal compounds
ES2119371T3 (es) * 1993-12-27 1998-10-01 Novartis Ag Aminocompuestos insaturados para usar como un agente anticancerigeno y antiprotozoico.
US5677350A (en) * 1995-06-07 1997-10-14 Wisconsin Alumni Research Foundation Inhibition of cancer cell growth, proliferation, and metastasis using N,N'-dα,ω-diaminoalkanes
CA2368801A1 (en) * 1999-04-30 2000-11-09 Slil Biomedical Corporation Conjugates as therapies for cancer and prostate diseases
US6482943B1 (en) * 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
US6794545B1 (en) * 1999-04-30 2004-09-21 Slil Biomedical Corporation Conformationally restricted polyamine analogs as disease therapies
US6649587B1 (en) 1999-04-30 2003-11-18 Slil Biomedical Corporation Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
AU2002235126A1 (en) * 2000-11-08 2002-05-21 Slil Biomedical Corporation Novel polyamine analog-amino acid conjugates useful as anticancer agents
US7045550B2 (en) * 2001-08-07 2006-05-16 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
US7030126B2 (en) * 2001-11-16 2006-04-18 Als Therapy Development Foundation, Inc. Use of polyamine analogs for amyotrophic lateral sclerosis
MXPA04005509A (es) * 2001-12-07 2004-12-06 Slil Biomedical Corp Poliaminas sustituidas con cicloalquilo para terapia de cancer y metodos de sintesis de las mismas.
KR20040091014A (ko) * 2002-02-07 2004-10-27 위스콘신 얼럼나이 리서어치 화운데이션 항암 요법과 병행해서 사용하기 위한 폴리아민 화합물 및조성물
PT2822936T (pt) 2012-03-07 2021-12-02 Univ Of Delhi Derivados da aminoquinolina e suas utilizações
CN102924390B (zh) * 2012-09-07 2014-12-31 苏州康润医药有限公司 1,5-二氮杂环辛烷-1-甲酸叔丁酯的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551550A (en) * 1983-12-06 1985-11-05 Merrell Dow Pharmaceuticals Inc. N-2,3-Butadienyl-1,4-butanediamine derivatives
GR81150B (en) * 1983-12-06 1985-04-03 Merrell Dow Pharma N-2,3- butadienyl-1,4-butanediamine derivatives
NZ223340A (en) * 1987-02-03 1991-03-26 Merrell Dow Pharma Polyamine derivatives and pharmaceutical compositions
US5120764A (en) * 1988-11-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase

Also Published As

Publication number Publication date
AU3927189A (en) 1990-02-08
HU207833B (en) 1993-06-28
KR900003105A (ko) 1990-03-23
EP0353752A1 (en) 1990-02-07
FI893681A0 (fi) 1989-08-03
CA1321603C (en) 1993-08-24
AU617502B2 (en) 1991-11-28
ES2061826T3 (es) 1994-12-16
FI893681A (fi) 1990-02-05
US4935449A (en) 1990-06-19
JP2722255B2 (ja) 1998-03-04
ATE99669T1 (de) 1994-01-15
NZ230155A (en) 1991-08-27
PT91365A (pt) 1990-03-08
JPH0283357A (ja) 1990-03-23
IL91184A0 (en) 1990-03-19
NO893135L (no) 1990-02-05
DE68912020D1 (de) 1994-02-17
EP0353752B1 (en) 1994-01-05
DK381189D0 (da) 1989-08-03
NO172043C (no) 1993-06-02
DK381189A (da) 1990-02-05
NO172043B (no) 1993-02-22
HUT58037A (en) 1992-01-28
DE68912020T2 (de) 1994-04-28
CN1039800A (zh) 1990-02-21
KR0144155B1 (ko) 1998-07-15
PH27214A (en) 1993-05-04
ZA895840B (en) 1990-04-25

Similar Documents

Publication Publication Date Title
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
AU586860B2 (en) Therapeutical application of phosphonylmethoxyalkyl adenines
FI870219A0 (fi) Hypoglykemiska tiazolidindioner.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE3785684T2 (de) Pyrrolidinamid-Derivate von Acylaminosäure, pharmazeutische Zusammensetzung und Verwendung.
NO893135L (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DE58902712D1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
DE68927055T2 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
FR2651230B1 (fr) Derives de la 5-amino-1,2,3,4 tetrahydro-acridine et applications comme medicaments.
DE69009211D1 (de) Derivate von Thiazolidin-4-carbonsäure, deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
KR900700484A (ko) 1,4:3,6-디안히드로 헥시톨 잘산염의 아미노프로판올 유도체,그의 제법 및 약제로서의 그의 용도
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
IT1213568B (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
IT8522758A0 (it) Composizione a base di fosfolipidi per la cura di affezioni neurologiche e procedimento per laloro preparazione.
FR2632861B1 (fr) Derives d'amino-4 carboxy-3 quinoleines et naphtyridines, leur procede de preparation et leur application comme medicaments
DK0580624T3 (da) Hidtil ukendte cytarabinderivater, fremstilling og anvendelse deraf
NO164651C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminofenol-derivater.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.
IT1213033B (it) Esteri di n-alchil-nortropine eloro derivati ammonioquaternari aventi attivita'anti-broncospastica, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
GR950100316A (el) Φαρμακευτικο παρασκευασμα βασιζομενο σε αιωρημα εμβρυικων κυτταρων με δραση ανοσοποιητικης υποκαταστασης και μεθοδος θεραπειας του συνδρομου της επικτητης μολυνσης ανοσοποιητικης ανεπαρκειας (hiv) με τη χρηση αυτου του παρασκευασματος.